| Code | CSB-RA004935MB6HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to VRCHIVMAB0115-00-AB, targeting the CD4 glycoprotein. CD4 is a transmembrane protein primarily expressed on T helper cells, regulatory T cells, monocytes, macrophages, and dendritic cells. It functions as a co-receptor for the T cell receptor (TCR), playing a critical role in immune cell activation and signal transduction. CD4 serves as the primary receptor for HIV-1 entry into host cells, making it central to HIV pathogenesis research. Additionally, CD4+ T cell populations are essential markers in immunology studies, autoimmune disease research, transplantation biology, and cancer immunotherapy investigations.
VRCHIVMAB0115-00-AB represents a research-grade reference antibody used in HIV research and immunological studies examining CD4-mediated cellular interactions. This biosimilar provides researchers with a reliable tool for investigating CD4 expression patterns, immune cell characterization, and viral entry mechanisms. It supports diverse experimental approaches in virology, immunology, and therapeutic development programs focused on immune modulation and infectious disease.
There are currently no reviews for this product.